UBS AM’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.3M | Buy |
176,719
+55,542
| +46% | +$2.61M | ﹤0.01% | 1451 |
|
|
2025
Q1 | $5.35M | Buy |
121,177
+2,125
| +2% | +$93.8K | ﹤0.01% | 1535 |
|
|
2024
Q4 | $4.3M | Buy |
119,052
+19,315
| +19% | +$698K | ﹤0.01% | 1681 |
|
|
2024
Q3 | $3.2M | Sell |
99,737
-13,898
| -12% | -$445K | ﹤0.01% | 1795 |
|
|
2024
Q2 | $4.28M | Buy |
113,635
+42,874
| +61% | +$1.62M | ﹤0.01% | 1575 |
|
|
2024
Q1 | $3.48M | Buy |
70,761
+1,248
| +2% | +$61.4K | ﹤0.01% | 1420 |
|
|
2023
Q4 | $2.54M | Buy |
69,513
+14,547
| +26% | +$531K | ﹤0.01% | 1566 |
|
|
2023
Q3 | $1.27M | Buy |
54,966
+12,336
| +29% | +$285K | ﹤0.01% | 1828 |
|
|
2023
Q2 | $1.1M | Hold |
42,630
| – | – | ﹤0.01% | 1960 |
|
|
2023
Q1 | $1.1M | Buy |
42,630
+15,712
| +58% | +$404K | ﹤0.01% | 1960 |
|
|
2022
Q4 | $700K | Buy |
26,918
+2,897
| +12% | +$75.4K | ﹤0.01% | 2032 |
|
|
2022
Q3 | $685K | Buy |
24,021
+8,113
| +51% | +$231K | ﹤0.01% | 2185 |
|
|
2022
Q2 | $392K | Sell |
15,908
-5,005
| -24% | -$123K | ﹤0.01% | 2387 |
|
|
2022
Q1 | $1.18M | Hold |
20,913
| – | – | ﹤0.01% | 2049 |
|
|
2021
Q4 | $1.3M | Hold |
20,913
| – | – | ﹤0.01% | 2065 |
|
|
2021
Q3 | $1.33M | Hold |
20,913
| – | – | ﹤0.01% | 2027 |
|
|
2021
Q2 | $1.72M | Buy |
20,913
+1,513
| +8% | +$125K | ﹤0.01% | 1924 |
|
|
2021
Q1 | $1.43M | Buy |
19,400
+3,800
| +24% | +$280K | ﹤0.01% | 1908 |
|
|
2020
Q4 | $1.13M | Buy |
15,600
+5,200
| +50% | +$377K | ﹤0.01% | 1926 |
|
|
2020
Q3 | $496K | Buy |
+10,400
| New | +$496K | ﹤0.01% | 2149 |
|